Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Receivables - Other (2009 - 2025)

Grifols' (GIFLF) quarterly Receivables - Other came in at $117.6 million in Q4 2025, up 41.05% on a YoY basis from $83.4 million in Q4 2024, and up 41.05% quarter-over-quarter from $83.4 million in Q4 2024.

Analysis

Grifols (GIFLF) Receivables - Other (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Receivables - Other for 17 consecutive years, with $117.6 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 41.05% year-over-year to $117.6 million; the trailing twelve-month figure through Dec 2025 stood at $117.6 million (up 41.05% YoY), and the FY2025 full-year result was $114.1 million, up 36.91% from the prior year.
  • Receivables - Other improved to $117.6 million in Q4 2025 per GIFLF's latest filing, from $83.4 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $117.6 million in Q4 2025 and bottomed at $63.0 million in Q4 2021.
  • Historically, Receivables - Other has averaged $83.8 million across 5 years, with a median of $80.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2025: Receivables - Other fell 26.99% in 2021, then jumped 41.05% in 2025.
  • Over 5 years, Receivables - Other stood at $63.0 million in 2021, then climbed by 18.53% to $74.7 million in 2022, then advanced by 7.98% to $80.6 million in 2023, then gained by 3.38% to $83.4 million in 2024, then soared by 41.05% to $117.6 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $117.6 million, $83.4 million, and $80.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 117.57 Mn
Dec 31, 2024 83.35 Mn
Dec 31, 2023 80.62 Mn
Dec 31, 2022 74.66 Mn
Dec 31, 2021 62.99 Mn
Dec 31, 2020 86.27 Mn
Dec 31, 2019 91.33 Mn
Dec 31, 2018 105.49 Mn
Jun 30, 2018 97.98 Mn
Dec 31, 2017 47.90 Mn
Jun 30, 2017 66.64 Mn
Dec 31, 2016 45.67 Mn
Sep 30, 2016 56.87 Mn
Jun 30, 2016 70.64 Mn
Dec 31, 2015 66.34 Mn
Sep 30, 2015 66.93 Mn
Jun 30, 2015 66,869.89
Mar 31, 2015 57.93 Mn
Dec 31, 2014 44.21 Mn
Sep 30, 2014 56.64 Mn